LIVER-LESION TISSUE CONTRAST ON MR IMAGES - EFFECT OF IRON-OXIDE CONCENTRATION AND MAGNETIC-FIELD STRENGTH

被引:20
作者
THICKMAN, D
HENDRICK, RE
JERJIAN, KA
SCHANKER, CS
机构
[1] Department of Radiology, University of Colorado, Health Sciences Center, Denver, CO 80262
关键词
D O I
10.1148/radiology.176.2.2367675
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This study assessed the enhancement of liver-lesion contrast by using low levels of iron oxide contrast agent at four common magnetic resonance (MR) imaging field strengths: 0.15, 0.35, 0.5, and 1.5 T. Adenocarcinomas were percutaneously inserted into the livers of 15 rats. Iron oxide was given intravenously in concentrations of 0 (control group), 2.5, 5, 10, and 20 μmol/kg to three rats in each concentration group. All images were acquired between 1 and 24 hours after injection. Liver-lesion contrast ratios and contrast-to-noise ratios (C/Ns) were calculated. Results showed increased liver-lesion contrast and C/Ns with increased iron oxide concentration up to 10-20 μmol/kg at all four magnetic field strengths. At 0.15 T, iron oxide produced lower gains in tumor-liver contrast. At middle and high magnetic field strengths, liver-lesion contrast was similar for each level of iron oxide concentration, but C/Ns were markedly higher at 1.5 T than at middle field strength. Low levels of iron oxide contrast agent are effective at magnetic field strengths of 0.35 T and above, producing the greatest increase in C/N at middle field strengths.
引用
收藏
页码:557 / 562
页数:6
相关论文
共 18 条
[1]  
BROGDON BG, 1983, RADIOL CLIN N AM, V21, P633
[2]   SUPERPARAMAGNETIC IRON OXIDE-ENHANCED MR IMAGING - PULSE SEQUENCE OPTIMIZATION FOR DETECTION OF LIVER-CANCER [J].
FRETZ, CJ ;
ELIZONDO, G ;
WEISSLEDER, R ;
HAHN, PF ;
STARK, DD ;
FERRUCCI, JT .
RADIOLOGY, 1989, 172 (02) :393-397
[3]  
ITOH K, 1989, RADIOLOGY, V173, P228
[4]   THE EFFECTS OF IRON-OXIDES ON PROTON RELAXIVITY [J].
JOSEPHSON, L ;
LEWIS, J ;
JACOBS, P ;
HAHN, PF ;
STARK, DD .
MAGNETIC RESONANCE IMAGING, 1988, 6 (06) :647-653
[5]  
KUSHNER JP, 1988, CECIL TXB MED, P898
[6]   DETECTION OF LIVER METASTASES WITH SUPERPARAMAGNETIC IRON-OXIDE IN 15 PATIENTS - RESULTS OF MR IMAGING AT 1.5-T [J].
MARCHAL, G ;
VANHECKE, P ;
DEMAEREL, P ;
DECROP, E ;
KENNIS, C ;
BAERT, AL ;
VANDERSCHUEREN, E .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1989, 152 (04) :771-775
[7]   A RAT MODEL OF LIVER-CANCER FOR IMAGING RESEARCH [J].
SAINI, S ;
STARK, DD ;
WITTENBERG, J ;
VICI, LG ;
BROWN, AS ;
FERRUCCI, JT .
INVESTIGATIVE RADIOLOGY, 1987, 22 (02) :149-152
[8]   FERRITE PARTICLES - A SUPERPARAMAGNETIC MR CONTRAST AGENT FOR ENHANCED DETECTION OF LIVER-CARCINOMA [J].
SAINI, S ;
STARK, DD ;
HAHN, PF ;
BOUSQUET, JC ;
INTROCASSO, J ;
WITTENBERG, J ;
BRADY, TJ ;
FERRUCCI, JT .
RADIOLOGY, 1987, 162 (01) :217-222
[9]   FERRITE PARTICLES - A SUPERPARAMAGNETIC MR CONTRAST AGENT FOR THE RETICULOENDOTHELIAL SYSTEM [J].
SAINI, S ;
STARK, DD ;
HAHN, PF ;
WITTENBERG, J ;
BRADY, TJ ;
FERRUCCI, JT .
RADIOLOGY, 1987, 162 (01) :211-216
[10]   SUPERPARAMAGNETIC IRON-OXIDE - CLINICAL-APPLICATION AS A CONTRAST AGENT FOR MR IMAGING OF THE LIVER [J].
STARK, DD ;
WEISSLEDER, R ;
ELIZONDO, G ;
HAHN, PF ;
SAINI, S ;
TODD, LE ;
WITTENBERG, J ;
FERRUCCI, JT .
RADIOLOGY, 1988, 168 (02) :297-301